Bivatuzumab

(Synonyms: BIWA 4; Anti-CD44 Recombinant Antibody)
Customer Review

Based on 1 Customer Validation

Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.

For research use only. We do not sell to patients.

  • Purity: 99.82%
  • CAS No.: 214559-60-1
  • Molecular Weight:143.22 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00